503A pharmacies can't legally compound it right now
Besides counteraction of bleeding aspirin-gastric ulcers (14), BPC 157 also counteracts other NSAIDs-toxicity, using the same dose range (8-14), namely, gastric and small intestine ulcers (i.e., induced by indomethacin, diclofenac, ibuprofen, celecoxib (8-14)), hepatotoxicity (paracetamol, diclofenac, ibuprofen, celecoxib) (8-14) and encephalopathy (paracetamol, diclofenac, ibuprofen, celecoxib) (8-14)
Transitioning between vials When your current vial runs low and you open a new one, maintain the same concentration
Published human clinical trials for KPV in IBD or arthritis are lacking
Research Use Only Free shipping on orders over $300 USD Premium research compounds Third-party COA available Secure checkout Fast order processing USD CAD EUR USD CAD EUR RESEARCH USE ONLY This product is for R&D purposes only and is not approved for human or veterinary use